loading
Schlusskurs vom Vortag:
$24.58
Offen:
$24.68
24-Stunden-Volumen:
87,082
Relative Volume:
0.35
Marktkapitalisierung:
$495.40M
Einnahmen:
$982.01M
Nettoeinkommen (Verlust:
$14.80M
KGV:
65.78
EPS:
0.37
Netto-Cashflow:
$37.02M
1W Leistung:
-0.56%
1M Leistung:
+24.86%
6M Leistung:
+4.57%
1J Leistung:
+35.65%
1-Tages-Spanne:
Value
$24.28
$24.68
1-Wochen-Bereich:
Value
$23.58
$25.25
52-Wochen-Spanne:
Value
$16.16
$26.55

Phibro Animal Health Corp Stock (PAHC) Company Profile

Name
Firmenname
Phibro Animal Health Corp
Name
Telefon
201-329-7300
Name
Adresse
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Name
Mitarbeiter
1,940
Name
Twitter
@phibroeurope
Name
Nächster Verdiensttermin
2024-12-06
Name
Neueste SEC-Einreichungen
Name
PAHC's Discussions on Twitter

Vergleichen Sie PAHC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
PAHC
Phibro Animal Health Corp
24.32 991.45M 982.01M 14.80M 37.02M 0.37
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
11.04 50.54B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
170.78 74.02B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
RDHL
Redhill Biopharma Ltd Adr
1.8576 4.22M 35.75M 11.57M -26.25M -3.8069
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.95 45.82B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
17.18 20.31B 16.54B -1.64B 749.00M -1.45

Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-09-10 Eingeleitet JP Morgan Neutral
2023-12-07 Eingeleitet Exane BNP Paribas Underperform
2022-12-21 Eingeleitet ROTH Capital Buy
2022-07-25 Herabstufung Barclays Equal Weight → Underweight
2022-01-10 Hochstufung Barclays Underweight → Equal Weight
2021-11-18 Eingeleitet Morgan Stanley Equal-Weight
2021-08-05 Fortgesetzt Credit Suisse Neutral
2021-07-07 Herabstufung Barclays Equal Weight → Underweight
2020-08-06 Herabstufung Morgan Stanley Equal-Weight → Underweight
2020-02-06 Herabstufung Gabelli & Co Buy → Hold
2020-01-28 Hochstufung Barclays Underweight → Equal Weight
2019-09-05 Hochstufung Morgan Stanley Underweight → Equal-Weight
2019-08-29 Bestätigt BofA/Merrill Underperform
2019-06-11 Eingeleitet Barclays Underweight
2019-05-23 Eingeleitet Guggenheim Neutral
2019-05-09 Hochstufung Gabelli & Co Hold → Buy
2017-08-23 Fortgesetzt BofA/Merrill Underperform
2017-06-02 Herabstufung Credit Suisse Outperform → Neutral
2016-12-15 Eingeleitet Piper Jaffray Overweight
2016-11-11 Herabstufung Macquarie Neutral → Underperform
2016-11-10 Herabstufung Gabelli & Co Buy → Hold
2016-04-11 Bestätigt Guggenheim Buy
2016-02-04 Eingeleitet Credit Suisse Outperform
2016-01-15 Herabstufung Barclays Overweight → Underweight
2015-09-30 Eingeleitet Gabelli & Co Buy
2015-04-24 Bestätigt Barclays Overweight
2015-04-21 Herabstufung Morgan Stanley Equal-Weight → Underweight
2014-05-06 Eingeleitet Barclays Overweight
Alle ansehen

Phibro Animal Health Corp Aktie (PAHC) Neueste Nachrichten

pulisher
Jun 02, 2025

Cetera Investment Advisers Takes $204,000 Position in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World

Jun 02, 2025
pulisher
May 31, 2025

Jane Street Group LLC Trims Stock Position in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World

May 31, 2025
pulisher
May 31, 2025

Deutsche Bank AG Boosts Stock Holdings in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World

May 31, 2025
pulisher
May 31, 2025

Ameriprise Financial Inc. Purchases 21,576 Shares of Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World

May 31, 2025
pulisher
May 30, 2025

Millennium Management LLC Has $4.36 Million Position in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World

May 30, 2025
pulisher
May 29, 2025

Phibro at Stifel Jaws & Paws Conference: Strategic Growth and Challenges - Investing.com India

May 29, 2025
pulisher
May 29, 2025

Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock - Yahoo Finance

May 29, 2025
pulisher
May 28, 2025

Is Phibro Animal Health (PAHC) Stock Undervalued Right Now? - Yahoo Finance

May 28, 2025
pulisher
May 27, 2025

Phibro Animal Health Co. (NASDAQ:PAHC) Shares Purchased by Lazard Asset Management LLC - Defense World

May 27, 2025
pulisher
May 27, 2025

Phibro Animal Health Co. (NASDAQ:PAHC) Shares Sold by BNP Paribas Financial Markets - Defense World

May 27, 2025
pulisher
May 27, 2025

D. E. Shaw & Co. Inc. Trims Stock Holdings in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World

May 27, 2025
pulisher
May 23, 2025

Best Value Stocks to Buy for May 23rd - Yahoo Finance

May 23, 2025
pulisher
May 22, 2025

Phibro Animal Health COO and Strategy Chief Set to Reveal Business Updates at Stifel Conference - Stock Titan

May 22, 2025
pulisher
May 21, 2025

What Makes Phibro Animal Health (PAHC) a Strong Momentum Stock: Buy Now? - Yahoo Finance

May 21, 2025
pulisher
May 21, 2025

Phibro Animal Health Co. (NASDAQ:PAHC) Shares Bought by Northern Trust Corp - Defense World

May 21, 2025
pulisher
May 15, 2025

Solid Earnings Reflect Phibro Animal Health's (NASDAQ:PAHC) Strength As A Business - Yahoo Finance

May 15, 2025
pulisher
May 13, 2025

Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term - Yahoo Finance

May 13, 2025
pulisher
May 13, 2025

International Markets and Phibro (PAHC): A Deep Dive for Investors - Yahoo Finance

May 13, 2025
pulisher
May 13, 2025

Phibro Animal Health Corporation (NASDAQ:PAHC) Q3 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025
pulisher
May 12, 2025

Phibro Animal Health Corp’s Earnings Call Highlights Robust Growth - TipRanks

May 12, 2025
pulisher
May 12, 2025

3 Reasons Growth Investors Will Love Phibro (PAHC) - Yahoo Finance

May 12, 2025
pulisher
May 12, 2025

Should Value Investors Buy Phibro Animal Health (PAHC) Stock? - Yahoo Finance

May 12, 2025
pulisher
May 12, 2025

Phibro Animal Health (NASDAQ:PAHC) Upgraded at StockNews.com - Defense World

May 12, 2025
pulisher
May 11, 2025

Phibro Animal Health (NASDAQ:PAHC) Shares Gap Down – Time to Sell? - Defense World

May 11, 2025
pulisher
May 10, 2025

Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12 - Yahoo Finance

May 10, 2025
pulisher
May 09, 2025

Phibro Animal Health (PAHC) Target Price Raised to $21 by Morgan Stanley | PAHC Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Phibro Animal Health Co. (NASDAQ:PAHC) Stake Trimmed by Dimensional Fund Advisors LP - Defense World

May 09, 2025
pulisher
May 09, 2025

Phibro Animal Health (NASDAQ:PAHC) Trading 12.6% Higher Following Better-Than-Expected Earnings - Defense World

May 09, 2025
pulisher
May 09, 2025

Phibro Animal Health Corp (PAHC) Q3 2025 Earnings Call Highlights: Robust Sales Growth and ... - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Phibro Animal Health Corp. Reaches Analyst Target Price - Nasdaq

May 09, 2025
pulisher
May 09, 2025

Phibro Animal Health Corp (PAHC) Q3 2025 Earnings Call Highlights: Robust Sales Growth and Strategic Investments Propel Performance - GuruFocus

May 09, 2025
pulisher
May 08, 2025

Earnings call transcript: Phibro Animal Health beats Q3 2025 expectations - Investing.com

May 08, 2025
pulisher
May 08, 2025

Phibro Q3 2025 slides: Animal Health segment drives 32% revenue surge By Investing.com - Investing.com South Africa

May 08, 2025
pulisher
May 08, 2025

Phibro Q3 2025 slides: Animal Health segment drives 32% revenue surge - Investing.com Canada

May 08, 2025
pulisher
May 08, 2025

Morgan Stanley Adjusts Price Target on Phibro Animal Health to $21 From $20, Maintains Equalweight Rating - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

Morgan Stanley Adjusts Phibro Animal Health (PAHC) Price Target Following Q3 Performance | PAHC Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Phibro Q3 Earnings Top Estimates, Stock Up, 2025 EPS Outlook Raised - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Envestnet Asset Management Inc. Buys New Stake in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World

May 08, 2025
pulisher
May 07, 2025

Compared to Estimates, Phibro (PAHC) Q3 Earnings: A Look at Key Metrics - Yahoo Finance

May 07, 2025
pulisher
May 07, 2025

Phibro: Fiscal Q3 Earnings Snapshot - MySA

May 07, 2025
pulisher
May 07, 2025

Phibro Animal Health (PAHC) Q3 Earnings Beat Estimates - Yahoo Finance

May 07, 2025
pulisher
May 07, 2025

Phibro Animal Health Corp reports results for the quarter ended March 31Earnings Summary - TradingView

May 07, 2025
pulisher
May 07, 2025

Phibro Animal Health Corp Reports Q3 EPS of $0.51, Beating Estim - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Phibro (PAHC) Sees Strong Q3 with Significant Gains in Animal He - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Phibro (PAHC) Sees Strong Q3 with Significant Gains in Animal Health Segment | PAHC Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Earnings Flash (PAHC) Phibro Animal Health Posts Q3 Revenue $347.8M, vs. FactSet Est of $352.2M - marketscreener.com

May 07, 2025
pulisher
May 07, 2025

Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance - Stock Titan

May 07, 2025
pulisher
May 06, 2025

Phibro Animal Health Sets June Dividend: What Shareholders Need to Know About the $0.12 Payout - Stock Titan

May 06, 2025
pulisher
May 05, 2025

Phibro Animal Health Corp expected to post earnings of 52 cents a shareEarnings Preview - TradingView

May 05, 2025
pulisher
May 05, 2025

Raymond James Financial Inc. Acquires Shares of 52,503 Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World

May 05, 2025
pulisher
May 03, 2025

BlackRock, Inc. Reduces Stake in Phibro Animal Health Corp - GuruFocus

May 03, 2025

Finanzdaten der Phibro Animal Health Corp-Aktie (PAHC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Phibro Animal Health Corp-Aktie (PAHC) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
CORCORAN E THOMAS
Director
Feb 24 '25
Buy
22.10
5,000
110,500
30,000
$8.425
price down icon 3.28%
drug_manufacturers_specialty_generic RDY
$14.62
price down icon 0.81%
$124.86
price down icon 0.01%
drug_manufacturers_specialty_generic HCM
$14.21
price up icon 2.99%
$324.39
price down icon 0.70%
$17.29
price up icon 0.03%
Kapitalisierung:     |  Volumen (24h):